Acute HIV Infection Clinical Trial
Official title:
Empiric Treatment for Suspected Acute HIV Infection in the Emergency Department
An acceptance and feasibility study for immediate ART initiation and storage of laboratory specimens for individuals with suspected acute HIV infection who are diagnosed in one of the 7 participating emergency rooms
Individuals with suspected acute HIV infection willing to start immediate ART treatment will be given the ART regimen (bictegravir 50mg + tenofovir alafenamide 25 mg + emtricitabine 200 mg fixed dose combination) on the day of diagnosis. Those patients beginning immediate ART in the ED who are willing to have additional laboratory specimens drawn in the ED and become part of a cohort to receive ART and have ongoing biological specimens obtained and will be followed for 48 weeks. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02384395 -
Safety and Efficacy of Fixed Dose Combination Dolutegravir/Abacavir/Lamivudine FDC Initiated During Acute HIV Infection
|
N/A | |
Completed |
NCT00734344 -
Pilot Study of Raltegravir/Truvada Versus Efavirenz/Truvada for Adults With Acute IV-1 Infection
|
N/A | |
Completed |
NCT01434706 -
Implementation of Nucleic Acid Amplification Testing Screening to Identify Acute and Early HIV Infection
|
N/A | |
Completed |
NCT01154673 -
Intense Acute Infection Study
|
Phase 2/Phase 3 | |
Terminated |
NCT00855413 -
HIV Viremia and Persistence in Acutely HIV-Infected Patients Treated With Darunavir/Ritonavir and Etravirine
|
Phase 4 | |
Completed |
NCT02467439 -
Acute Partner and Social Contact Referral: iKnow
|
N/A | |
Not yet recruiting |
NCT05719441 -
A Clinical Trial of Combination HIV-Specific Broadly Neutralizing Monoclonal Antibodies Combined With ART Initiation During Acute HIV Infection to Induce HIV Remission
|
Phase 2 | |
Completed |
NCT03579381 -
Specimen Repository for HIV Immunopathogenesis
|
||
Completed |
NCT01369056 -
HAART Adherence Among HIV-infected Persons and the Factors Affecting Treatment Adherence
|
N/A | |
Completed |
NCT02170246 -
Analysis of Telmisartan Administered With Antiretroviral Therapy (ART) in Patients With Acute HIV Infection
|
Phase 1 | |
Completed |
NCT02750059 -
Using Telmisartan With ART During Acute HIV Infection to Reduce the CNS Reservoirs of HIV and Lymph Node Fibrosis
|
Phase 2 | |
Completed |
NCT02475915 -
Efficacy of VHM After Treatment Interruption in Subjects Initiating ART During Acute HIV Infection
|
Phase 1/Phase 2 | |
Completed |
NCT02470351 -
Assessment of the HIV CNS Reservoir, Neurological and Neuro-cognitive Effects, and Source of Rebound HIV in CNS
|
N/A | |
Completed |
NCT00924898 -
Treatment of Acute HIV With Emtricitabine, Tenofovir and Efavirenz (CID 0805)
|
Phase 4 | |
Completed |
NCT02614950 -
Viral Suppression After Analytic Treatment Interruption in Thai Patients Who Initiated Highly Active Antiretroviral Therapy During Acute HIV Infection
|
N/A | |
Completed |
NCT01197027 -
Feasibility and Acceptability Study of an Individual-Level Behavioral Intervention for Individuals With Acute and Early HIV-Infection
|
Phase 3 | |
Active, not recruiting |
NCT02231281 -
Early cART and cART in Combination With Autologous HIV-1 Specific Cytotoxic T Lymphocyte (CTL) Infusion in The Treatment of Acute HIV-1 Infected Adults
|
Phase 3 | |
Recruiting |
NCT05728996 -
Netherlands Cohort Study on Acute HIV Infection
|
||
Recruiting |
NCT00796263 -
Antiretroviral Therapy for Acute and Chronic HIV Infection
|
Phase 3 | |
Recruiting |
NCT00796146 -
Establish and Characterize an Acute HIV Infection Cohort in a High Risk Population
|